Here’s Tilray Brands numbers vs Curaleaf I was asked to prove Tilray Brands finacial liqudity vs its largest cannabis peer south of the border Curaleaf.
This is relevent to Tilray Brands as we make comparisons between Tilray Brands TLRY and its peers.
Taken from Tilray brands transcript call
-
Achieved $17.1 million in annualized run-rate savings (and $2.9 million in actual cash cost savings) as part of the $27 million synergy plan related to the HEXO acquisition. We are on target to achieve our integration plan goals and we are confident HEXO will prove to be a successful acquisition.
-
Achieved $6.8 million in annualized run-rate savings in connection with the $8.0 million cost reduction plan in Europe.
-
Strong financial liquidity position of ~$466 million
Taken from Curaleaf transcript call
- Adjusted net loss from continuing operations attributable to Curaleaf Holdings, Inc.(1) of $70.8 million or adjusted net loss per share(1) of $0.10
- Adjusted EBITDA(1) of $75.3 million or 23% of revenue
- Exited direct operations in Michigan and Kentucky resulting in a $22 million non-cash impairment charge, and $3 million in adjusted EBITDA accretion
- Cash at quarter end totaled $118.1 million